Support PBS listing for three adjuvant treatments of resected Stage III melanoma

13 May 2019
The Pharmaceutical Benefits Advisory Committee is considering three treatments for the adjuvant treatment of resected Stage III melanoma at their July meeting.
Part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
Submissions will be accepted until Wed 12 June 2019, and they can be made as follows:
- Email your input directly to the PBAC at CommentsPBAC@health.gov.
au - Mail your submission to the PBAC Secretariat: MDP 952, Department of Health and Ageing, GPO Box 9848, Canberra ACT
2601 - There is also an online portal for
submission
Please note that if you are submitting via the online portal, there are two submissions for

Global Melanoma Research Report - April
In this Global Research Report we showcase advances in medical oncology, reveal unexpected pathology in acral and skin melanoma, and uncover biomarkers and new gene targets for melanoma.

The people behind the Professors
Professor’s Long and Scolyer are well known in the academic community and beloved by their patients. But we wanted to get to know our new Conjoint Medical Directors a little more and hear their plans on making an impact on melanoma.

Wyong Rugby Leagues kicks goal to help end melanoma
Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.

Melanoma research reaches a milestone
Melanoma research has reached a milestone with the 10,000th patient giving their permission for their blood and tissue samples to be used in the world’s largest melanoma biospecimen bank.

Contributing to the promise of Surgical Oncology
MIA's researchers and clinicians are in Seattle, USA, today sharing their research findings at the prestigious Society of Surgical Oncology’s Annual Cancer Symposium.

Introducing Melanoma Institute Australia's Conjoint Medical Directors
Two of the world’s best minds in melanoma have taken over the academic and clinical leadership of Melanoma Institute Australia (MIA). Professor Georgina Long and Professor Richard Scolyer are the new Conjoint Medical Directors of MIA, and are shaping the future direction of melanoma research, treatment and education.

A day in the life of... Georgia Cairns CNC
Meet Georgia, our Clinica Nurse Consultant who provides vital care and education for patients throughout their treatment.

The real tragedy on Married At First Sight that Australia should be talking about....
Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.

Melanoma Institute Australia celebrates International Women's Day
To celebrate International Women's Day 2017, MIA shares how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.

New Chairman of the Board for Melanoma Institute Australia
We welcome Mr Grant King to the position of Chairman of the Board of Melanoma Institute Australia, following the retirement of Mr Reg Richardson AM who led the organisation for 10 years.

MIA student honoured with NSW National Council of Women Australia Day Award
Congratulations to PhD Student, Tuba Nur Gide who was awarded a NSW National Council of Women Australia Day Award for her PhD research work.

Melanoma Institute Australia joins forces with Wollongong Wolves in the fight against melanoma
Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.

Follow-up scans after surgery for melanoma
A new research project will evaluate the benefits and economic implications of CT and PET/CT imaging in patients with asymptomatic Stage III melanoma.

Sunscreen tips for a skin smart summer!
Sunscreen tips for a skin smart summer with the help of Professor Pascale Guitera, Dermatologist Associate for Melanoma Institute Australia.

Improving survival in uveal melanoma
Although survival rates for people with skin melanoma are increasing, these promises of hope are not being seen in uveal melanoma. Researchers are desperately trying to uncover new ways to treat this disease.

Melanoma prevention and awareness on 720 ABC Perth
Lucinda Ryan and Carole Renouf talking about melanoma preventation and awareness on 720 ABC Perth.

Melanoma research gets a funding boost from NHMRC
Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.

Challenges in melanoma clinical research
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.

Global Melanoma Research Report
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.

Announcement from Melanoma Institute Australia
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.